Target intelligence / Profile preview

Tubulin alpha pseudogene 7 (TUBAP7)

Target
TUBAP7
Molecular classification
Other (Pseudogene), Related to tubulin alpha family
01

Overview

Tubulin alpha pseudogene 7 (TUBAP7) is a non-coding genomic sequence annotated as a pseudogene in the tubulin alpha family. Pseudogenes such as TUBAP7 are non-functional remnants of gene duplication or retrotransposition events, sharing sequence similarity with functional alpha-tubulin genes but lacking protein-coding potential due to disabling mutations or truncation. Unlike functional tubulin alpha genes, which encode proteins that shape microtubules and are implicated in neurological disease and targeted by drugs[1][2], TUBAP7 has no direct biological function, disease association, nor therapeutic relevance. Its presence is relevant only for evolutionary or genomic reference, not for pharmacological targeting. Critical context: - While some protein-coding tubulin alpha genes (e.g., TUBA1A) are important cytoskeletal proteins and are involved in diseases such as lissencephaly and are targets for anti-microtubule drugs[1][2], TUBAP7 is not among those and does not encode a protein product. - Pseudogenes are sometimes transcribed, but their RNAs typically have no biological function or clinical use. - The inclusion of TUBAP7 as a therapeutic "target" or biomarker is incorrect based on current scientific criteria[3].

Other names
Tubulin alpha 4a pseudogeneTUBAP7
02

Mechanism of action

None (pseudogenes are not targeted by drugs as they do not produce targetable proteins)

03

Biological functions

None (as a pseudogene, TUBAP7 does not encode a functional protein and has no demonstrated biological function)
04

Disease associations

None (no evidence for clinical or disease association for TUBAP7 pseudogene; tubulin alpha coding genes are associated with certain neurological diseases, but pseudogenes generally lack such roles)
05

Safety considerations

None (no therapeutic interventions or safety challenges pertaining to pseudogenes)
06

Interacting drugs

None (no drugs are described to interact with pseudogenes)
07

Biomarkers

None (not used as a biomarker for patient selection or monitoring)

Beyond the preview

Go deeper on Tubulin alpha pseudogene 7 (TUBAP7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tubulin alpha pseudogene 7 (TUBAP7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call